SPECIAL REPORT - When the drugs don't work

big drug companies have decided to end their antibiotic research, including Roche Holding AG, Bristol-Myers Squibb Co and Eli Lilly & Co. AstraZeneca and GlaxoSmithKline -- and to a lesser extent Novartis AG, Merck & Co Inc and Pfizer Inc -- remain in...